Sign In
Buy TNXP
$12.20
+0.190 (+1.58%)
At Close: Jun 22, 2026
World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of international concern (PHEIC) 1
FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate
07:45am, Thursday, 01'st Aug 2024
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations
Fibromyalgia is a “diagnosable condition” in people suffering from Long COVID according to NASEM 1
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
08:00am, Thursday, 25'th Jul 2024
Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill an unmet medical need
Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025
08:00am, Wednesday, 17'th Jul 2024
CHATHAM, NJ / ACCESSWIRE / July 17, 2024 / With the completion of its final pre-NDA meeting with the FDA, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced it is filing an NDA submission in
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
04:30pm, Wednesday, 10'th Jul 2024
CHATHAM, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced th
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
09:15am, Tuesday, 09'th Jul 2024
CHATHAM, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it
Tonix Pharmaceuticals Announces Proposed Public Offering
05:00pm, Monday, 08'th Jul 2024
CHATHAM, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced th
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
08:00am, Monday, 08'th Jul 2024
Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10 million adults in the U.S. are affected by fibromyalgia, predominantly w
Defense Threat Reduction Agency (DTRA) contract is expected to advance development of Tonix's broad-spectrum oral antiviral program TNX-4200 for medical countermeasures Defense Threat Reduction Agency
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
04:05pm, Friday, 28'th Jun 2024
CHATHAM, N.J., June 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced th
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
08:37am, Thursday, 27'th Jun 2024
Tonix Pharmaceuticals (NASDAQ: TNXP ) stock is falling on Thursday after the biopharmaceutical company announced a proposed public offering for its shares. Tonix Pharmaceuticals doesn't have the fine
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
08:36am, Thursday, 27'th Jun 2024
CHATHAM, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it
Tonix Pharmaceuticals Announces Proposed Public Offering
04:40pm, Wednesday, 26'th Jun 2024
CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced th
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
03:13pm, Wednesday, 26'th Jun 2024
CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company, today announced that it has re
